PetCaseFinder

Peer-reviewed veterinary case report

Cat heart muscle thickening linked to acute liver infection

By Byung-Jun Kim et al.·Published in Frontiers in Veterinary Science·2026·College of Veterinary Medicine, Chungnam National University, Daejeon, Republic of Korea, CH·View original on DOAJ

PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →

Original publication title: Case Report: Transient myocardial thickening in a cat secondary to acute cholangiohepatitis

Species:
cat

Plain-English summary

A 3-year-old male Abyssinian cat was brought in with liver inflammation (acute cholangiohepatitis) and showed signs of heart issues, including thickening of the heart muscle. Initially, tests showed elevated liver enzymes and heart markers, but after treatment with antibiotics and other medications, his liver values improved. However, his heart markers unexpectedly spiked, leading to further heart evaluations that confirmed the thickening. The vet added a heart medication called atenolol to his treatment plan. After 84 days of follow-ups, both his liver and heart markers returned to normal, and his heart size improved.

People also search for: cat heart problems treatment · Abyssinian cat liver disease · cat cholangiohepatitis symptoms

Abstract

Transient myocardial thickening (TMT) has been reported mainly in young cats following systemic triggers such as anesthesia, surgery, acute stress, or infection; however, to the authors’ knowledge, TMT secondary to acute cholangiohepatitis has not been described. A 3-year-old, 5.8-kg castrated male Abyssinian was referred with acute cholangiohepatitis. Initial evaluation revealed increased hepatic enzymes and bilirubin, elevated cardiac troponin I (cTnI, 3.5 ng/mL), and mildly increased N-terminal pro-B-type natriuretic peptide (NT-proBNP, 102.6 pmol/L). On the day of discharge, despite improving hepatic indices, cTnI rose abruptly to 8.0 ng/mL and NT-proBNP exceeded 1,500 pmol/L. Echocardiography demonstrated septal thickening, left atrial enlargement, and systolic anterior motion of the mitral valve, consistent with TMT. Atenolol was added to the outpatient medical management for cholangiohepatitis, consisting of broad-spectrum antimicrobials, hepatoprotectants, and antiemetic/gastroprotective agents. Over the course of 84 days, five follow-up evaluations were performed, during which hepatic values normalized, cTnI and NT-proBNP returned to reference ranges, and myocardial dimensions and vertebral heart score normalized. Unlike most reports in which TMT is identified after congestive signs develop, this case was recognized earlier, on the basis of an abrupt biomarker surge during apparent clinical improvement.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication on DOAJ: https://doi.org/10.3389/fvets.2025.1703872